Market revenue in 2023 | USD 54.8 million |
Market revenue in 2030 | USD 134.4 million |
Growth rate | 13.7% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 26.46% in 2023. Horizon Databook has segmented the Germany research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
The growing collaboration among organizations to enhance research study in Germany propels research-grade proteins market growth. For instance, in April 2023, a German-based Clinical Research Organization (CRO), Taros Chemical, collaborated with Welab Barcelano, a Spain-based drug discovery & development center, to enhance and support the research & development process.
Similarly, in September 2023, CureVac, a German mRNA specialist, in partnership with pharmaceutical giant GSK, provided details about the progression of their modified seasonal influenza mRNA vaccine candidate with multivalent properties into Phase II clinical trials.
For instance, in June 2022, Merck partnered with Agilent Technologies to expand the capabilities of real-time monitoring & automated control of vital process parameters and quality attributes within Downstream Processing (DSP).
Horizon Databook provides a detailed overview of country-level data and insights on the Germany research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Germany research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account